Vascular endothelial growth factor trap-eye (Aflibercept) for the management of diabetic macular edema

Diabetic retinopathy (DR) is the most common cause of visual loss among working age individuals. Diabetic macular edema (DME) is an important complication of DR that affects around one third of the patients with DR. Several treatments have been approved for DME ranging from blood pressure and glycem...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Moradi, Ahmadreza, Sepah, Yasir Jamal, Sadiq, Mohammad Ali, Nasir, Humzah, Kherani, Salima, Sophie, Raafay, Do, Diana V, Nguyen, Quan Dong
Formato: Artigo
Lenguaje:Inglês
Publicado: Baishideng Publishing Group Co., Limited 2013
Materias:
Topic Highlight
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3874490/
https://ncbi.nlm.nih.gov/pubmed/24379921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v4.i6.303
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares